The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bogdanova A.A.

City Clinical Polyclinic No. 6

Kravtsunova E.S.

Stavropol State Medical University

Raevskaya A.I.

Stavropol State Medical University

Karpov An.S.

Stavropol State Medical University

Gadaborshev R.N.

Stavropol State Medical University

Dzutsev A.I.

Stavropol State Medical University

Vyshlova I.A.

Stavropol State Medical University

Karpov S.M.

Stavropol State Medical University

Guillain—Barre syndrome associated with COVID-19

Authors:

Bogdanova A.A., Kravtsunova E.S., Raevskaya A.I., Karpov An.S., Gadaborshev R.N., Dzutsev A.I., Vyshlova I.A., Karpov S.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9): 132‑136

DOI: 10.17116/jnevro2022122091132

Read: 3193 times

Download PDF (RU)
Contact the author
Table of contents

GUILLAIN—BARRE SYNDROME ASSOCIATED WITH COVID-19
GUILLAIN—BARRE SYNDROME ASSOCIATED WITH COVID-19

To cite this article:

Bogdanova AA, Kravtsunova ES, Raevskaya AI, et al. Guillain—Barre syndrome associated with COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(9):132‑136. (In Russ.)
https://doi.org/10.17116/jnevro2022122091132

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):120-127
SpO2/RR index in choosing the method for correction of acute respiratory failure in COVID-19 patients. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):50-58
Post-Covid aortitis with cardiac invo­lvement: progressive aortic aneurysm combined with active myocarditis. Russian Journal of Archive of Pathology. 2025;(2):53-58
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
Impact of the COVID-19 epidemic on students’ health. Part II. Features of hemo­dynamics, vege­tative regu­lation, resu­lts of psychological and stress resi­stance testing among students depe­nding on the COVID-19 presence in their medi­cal history. Russian Journal of Preventive Medi­cine. 2025;(4):94-101
A rare case of endo­metrial stro­mal sarcoma of the cervix and vagina in a 17-year-old patient with abno­rmal uterine bleeding. Russian Journal of Human Reproduction. 2025;(2):86-91
Sellar collision tumors: difficulties of preoperative neuroimaging and sele­ction of surgical approach. Case repo­rts and lite­rature review. Burdenko's Journal of Neurosurgery. 2025;(3):75-82
Mela­noma of the maxi­llary sinus mucosa. Stomatology. 2025;(2):82-85
Mathematical mode­ling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49
Abstract:

This paper reports two cases of Guillain-Barre syndrome associated with coronavirus infection COVID-19. The clinical symptoms and neurological status of patients, the data of the additional examination and the features of the prescribed therapy are described in detail. The issue of the tropicity of the SARS-CoV-2 virus to human nervous tissue and its possible ways of affecting the peripheral nervous system is discussed.

Keywords:

Guillain—Barre syndrome
COVID-19
clinical case
peripheral nervous system

Authors:

Bogdanova A.A.

City Clinical Polyclinic No. 6

Kravtsunova E.S.

Stavropol State Medical University

Raevskaya A.I.

Stavropol State Medical University

Karpov An.S.

Stavropol State Medical University

Gadaborshev R.N.

Stavropol State Medical University

Dzutsev A.I.

Stavropol State Medical University

Vyshlova I.A.

Stavropol State Medical University

Karpov S.M.

Stavropol State Medical University

Received:

25.04.2022

Accepted:

06.06.2022

Close metadata

References:

  1. Raevskaya AI, Shevchenko PP, Karpov SM. Modern methods of diagnosis and treatment of Guillain—Barre syndrome. Vestnik Molodogo Uchenogo. 2019;8(4):136-141. Accessed: 13.02.2022. (In Russ.). https://www.elibrary.ru/item.asp?id=42748999
  2. https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/_kr_sgb.pdf  https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoy-pomoshchi/_kr_sgb.pdf
  3. Suponeva NA, Piradov MA, Gnedovskaya EV. The Guillain-Barre syndrome in cities of the Russian Federation: epidemiology, diagnostic and therapeutic possibilities of regional polyclinics. Zdravoohranenie Rossijskoj Federacii. 2013;1:19-251. Accessed: 13.02.22. (In Russ.). https://cyberleninka.ru/article/n/sindrom-giyena-barre-v-gorodah-rossiyskoy-federatsii-epidemiologiya-diagnosticheskie-i-terapevticheskie-vozmozhnosti-regionalnyh
  4. Bondar SA, Maslyansky AL, Smirnova AYu, et al. Guillain-Barré syndrome and COVID-19: clinical cases. RMJ. 2021;5:60-64. Accessed: 13.02.22. (In Russ.). https://www.rmj.ru/articles/nevrologiya/Sindrom_Giyena__Barre_i_COVID-19_klinicheskie_nablyudeniya
  5. Chajkovskaja AD, Ivanova AD, Ternovyh IK, et al. Guillain-Barre syndrome on the background of COVID-19 infection. Sovremennye Problemy Nauki i Obrazovanija. 2020;4:23-28. (In Russ.). https://doi.org/10.17513/spno.29950
  6. Shakaryan AK, Pylaeva SK, Perekopskaya NE, et al. Guillain—Barre syndrome with cranial nerve damage as complication of COVID-19. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(9):100-103. (In Russ.). https://doi.org/10.17116/jnevro2021121091100
  7. Shirshova EV, Knaub VV, Baklaushev VP. A. Clinical Case of Guillain-Barré Syndrome Associated with COVID-19. Journal of Clinical Practice. 2021;12(2):110-118. (In Russ.). https://doi.org/10.17816/clinpract72264
  8. https://neuromuscular.ru/wp-content/uploads/2020/10/KR-SGB-2020-FINAL.pdf  https://neuromuscular.ru/wp-content/uploads/2020/10/KR-SGB-2020-FINAL.pdf
  9. Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(1):33-43.  https://doi.org/10.1093/brain/awt285
  10. Abu-Rumeileh S, Abdelhak A, Foschi M, et al. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133-1170. https://doi.org/10.1007/s00415-020-10124-x
  11. Garg RK. Spectrum of Neurological Manifestations in Covid-19: A Review. Neurol India. 2020;68(3):560-572.  https://doi.org/10.4103/0028-3886.289000
  12. Gupta A, Paliwal VK, Garg RK. Is COVID-19-related Guillain-Barré syndrome different? Brain Behav Immun. 2020;87:177-178.  https://doi.org/10.1016/j.bbi.2020.05.051
  13. Shoraka S, Ferreira MLB, Mohebbi SR, Ghaemi A. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms. Front Immunol. 2021;12:674922. https://doi.org/10.3389/fimmu.2021.674922
  14. Belopasov VV, Yachou Y, Samoilova EM, Baklaushev VP. The nervous system damage in COVID-19. Journal of Clinical Practice. 2020;11(2):60-80. (In Russ.). https://doi.org/10.17816/clinpract34851
  15. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995-998.  https://doi.org/10.1021/acschemneuro.0c00122
  16. Martynov MYu, Bogolepova AN, Yasamanova AN. Endothelial dysfunction in COVID- 19 and cognitive impairment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(6):93-99. (In Russ.). https://doi.org/10.17116/jnevro202112106193
  17. https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/BMP_COVID-19_V15.pdf  https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/BMP_COVID-19_V15.pdf
  18. Jarius S, Pache F, Körtvelyessy P, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19(1):19.  https://doi.org/10.1186/s12974-021-02339-0
  19. Arnaud S, Budowski C, Ng Wing Tin S, Degos B. Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol. 2020;131(7):1652-1654. https://doi.org/10.1016/j.clinph.2020.05.003
  20. Finsterer J, Almas T. Guillain-Barré syndrome is immunogenic in SARS-CoV-2 infected. J Med Virol. 2022;94(1):22-23.  https://doi.org/10.1002/jmv.27314
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.